ATH
Click for more information
11.1% 0.5¢ alterity therapeutics limited

Ann: UK Regulatory Authorisation to Proceed with Phase 2 Trial, page-9

  1. lwlinwei
    405 Posts.
    lightbulb Created with Sketch. 38
    clock Created with Sketch.
    29/04/22
    12:20
    Post #: 61099227
    Very true! They always used "expect" and kept delaying everything, like the biomuse and P2 trial.

    Nobody will trust them again if they do it again once more...
    ATH Price at posting: 1.8¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

STN Saturn’s stars have aligned for the gold explorer’s Apollo Project
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
ITM Fast-track assaying yields 182 g/t gold for iTech at new NT play
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
0.001(11.1%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $4.263K 916.0K

Buyers (Bids)

No. Vol. Price($)
58 69165915 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 38212524 21
View Market Depth
Last trade - 15.11pm 05/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.